SCHEMBL10378397

SCHEMBL10378397

Cn1ccc(C=C[N+](=O)[O-])c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FBP1 P09467 14/20 0.52
ALDH1A1 P00352 3/20 0.47
LMNA P02545 3/20 0.47
MAPT P10636 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
EGFR P00533 2/20 0.47
MITF O75030 1/20 0.45
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
VCP P55072 1/20 0.44
ABL1 P00519 1/20 0.43
ABL2 P42684 1/20 0.43
S1PR4 O95977 1/20 0.42
HSP90AA1 P07900 1/20 0.42
HPGD P15428 1/20 0.42
S1PR1 P21453 1/20 0.42
MAPK1 P28482 1/20 0.42
CCR6 P51684 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
TLR9 Q9NR96 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10378395 1.00 FBP1 (0.52) FBP1ALDH1A1LMNAMAPTSMN1; SMN2
SCHEMBL6910818 0.73 FBP1 (0.78) FBP1ALDH1A1LMNAMAPTSMN1; SMN2
SCHEMBL6910815 0.73 FBP1 (0.78) FBP1ALDH1A1LMNAMAPTSMN1; SMN2
SCHEMBL24664061 0.71 ALDH1A1 (0.45) ALDH1A1LMNAMAPTMAPK1
SCHEMBL510539 0.69 HSP90AA1 (0.55) FBP1ALDH1A1LMNAMAPTSMN1; SMN2
SCHEMBL510540 0.69 HSP90AA1 (0.55) FBP1ALDH1A1LMNAMAPTSMN1; SMN2
SCHEMBL17848061 0.69 MAOA (0.47) FBP1ALDH1A1LMNAMAPTSMN1; SMN2
SCHEMBL17848062 0.69 MAOA (0.47) FBP1ALDH1A1LMNAMAPTSMN1; SMN2
SCHEMBL8800866 0.68 FBP1 (0.51) FBP1ALDH1A1LMNASMN1; SMN2EGFR
SCHEMBL366122 0.68 FBP1 (1.00) FBP1ALDH1A1LMNAMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0172692-B1 HEXAHYDROINDOLIZINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS AND INTERMEDIATES McNeilab, Inc. (US) 1990-04-18 EP disclosed
EP-0172692-A1 Hexahydroindolizine compounds, pharmaceutical compositions and methods and intermediates McNeilab, Inc. (US) 1986-02-26 EP disclosed
US-4572911-A ANTISECRETORY AND ANTIDEPRESSANT AGENTS MCNEILAB, INC. (US) 1986-02-25 US disclosed
US-4002643-A REARRANGING WITH A STRONG, ANHYDROUS, NON-OXIDIZING ACID MCNEIL LABORATORIES, INC. (US) 1977-01-11 US disclosed